Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
73
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
96
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Generation Development Group
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Managed Accounts And Annuities Will Navigate Integration And Tax Risks
Key Takeaways Expansion into managed accounts and strategic acquisitions position the company as a market leader, with opportunities for revenue growth driven by industry changes. A capital-light model and demographic trends boost efficiency and margins, increasing dividends and enhancing earnings, while new products and reforms drive sales growth.
View narrative
AU$5.97
FV
6.8% overvalued
intrinsic discount
-23.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
18 days ago
author updated this narrative
LENSAR
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Global System Placements Will Improve Operating Room Efficiency
Key Takeaways Strong system placements and contract pipelines in international markets enhance potential for sustained revenue growth and competitive advantage. Strategic focus on ALLY System adoption in diverse settings and converting competitive users drives increased productivity, recurring revenues, and profitability.
View narrative
US$15.00
FV
14.2% undervalued
intrinsic discount
28.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
18 days ago
author updated this narrative
Triple Flag Precious Metals
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Acquisitions And Projects Will Expand Nevada And Peru Mining Operations
Key Takeaways Strategic acquisitions such as Orogen Royalties bolster revenue growth through valuable gold and silver projects and appear poised to enhance future production potential. Debt-free status and high liquidity empower continued strategic investments with strong shareholder returns, leveraging favorable precious metal market conditions.
View narrative
CA$39.52
FV
8.0% undervalued
intrinsic discount
10.17%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
18 days ago
author updated this narrative
Phathom Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Focused VOQUEZNA Marketing And Cost Cuts Will Secure 2032 Exclusivity
Key Takeaways Phathom focuses on VOQUEZNA's market potential in GERD treatment to drive substantial revenue while aiming for profitability through strategic cost management. New strategies and leadership in sales and marketing are set to optimize operations, potentially extending VOQUEZNA's market exclusivity and enhancing financial performance.
View narrative
US$19.88
FV
51.0% undervalued
intrinsic discount
92.52%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
18 days ago
author updated this narrative
Amtech Systems
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
AI Infrastructure And Advanced Packaging Will Strengthen US Semiconductor Manufacturing
Key Takeaways Surging demand for advanced packaging, digitalization trends, and supply chain shifts strengthen Amtech’s market position, fueling potential revenue growth and operational leverage. Expanded high-margin recurring revenue streams and effective cost reductions increase profitability, decrease earnings volatility, and enhance margin stability even during cyclical downturns.
View narrative
US$6.00
FV
19.2% undervalued
intrinsic discount
2.94%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
18 days ago
author updated this narrative
UroGen Pharma
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
FDA Approval And Expanding Pipeline Will Advance Uro-Oncology
Key Takeaways Imminent launch of UGN-102 and demographic trends are set to drive substantial revenue and market expansion for UroGen Pharma. Diversification of pipeline assets and favorable clinical outcomes enhance stability, pricing power, and reduce reliance on a single product.
View narrative
US$34.38
FV
48.4% undervalued
intrinsic discount
66.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
18 days ago
author updated this narrative
PENN Entertainment
AN
AnalystConsensusTarget
Consensus Narrative from 18 Analysts
Omnichannel Integration And iGaming Legalization Will Create Value
Key Takeaways Growing digital platform and physical property upgrades are increasing customer engagement, recurring revenue potential, and margin expansion through enhanced cross-sell and technology integration. Regulatory tailwinds and prudent capital management position the company for stronger earnings, improved cash flow, and reduced risk in an evolving gaming market.
View narrative
US$21.89
FV
22.5% undervalued
intrinsic discount
5.61%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
18 days ago
author updated this narrative
Alto Ingredients
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
International Renewable Fuels And Legislation Will Unlock Future Opportunities
Key Takeaways Expansion into premium international markets and rising demand for low-carbon products support revenue growth and margin improvement. Cost-cutting initiatives and operational upgrades enhance profitability, competitiveness, and long-term cash flow stability.
View narrative
US$4.00
FV
73.5% undervalued
intrinsic discount
1.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
18 days ago
author updated this narrative
Armada Hoffler Properties
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Sun Belt And Southeast Urbanization Will Fuel Mixed Use Demand
Key Takeaways Strategic focus on mixed-use, walkable urban properties in high-growth regions drives strong occupancy, rent growth, and resilience to shifting tenant demands. Active portfolio management and cost controls increase flexibility, allowing reinvestment and supporting sustained earnings consistency and risk-adjusted long-term growth.
View narrative
US$8.50
FV
18.2% undervalued
intrinsic discount
-36.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
18 days ago
author updated this narrative
Value any company in seconds
Popular companies